The standard-of-care in breast cancer (BC) with positive sentinel lymph node (SLN) metastasis includes complete axillary lymph node dissection (ALND); however, almost half of such cases have no further tumor burden. This study aimed to assess the clinicopathological factors that predict non-SLN metastasis to define subgroups of SLN-positive patients in whom the axilla may be staged by SLN biopsy alone, while avoiding unnecessary overtreatment.

Orsaria, P., Caredda, E., Genova, F., Materazzo, M., Capuano, I., Vanni, G., et al. (2018). Additional nodal disease prediction in breast cancer with sentinel lymph node metastasis based on clinicopathological features. ANTICANCER RESEARCH, 38(4), 2109-2117 [10.21873/anticanres.12451].

Additional nodal disease prediction in breast cancer with sentinel lymph node metastasis based on clinicopathological features

Orsaria P.;Vanni G.;Granai A. V.;de Majo A.;Sileri P.;Petrella G.;Palombi L.;Buonomo O. C.
2018

Abstract

The standard-of-care in breast cancer (BC) with positive sentinel lymph node (SLN) metastasis includes complete axillary lymph node dissection (ALND); however, almost half of such cases have no further tumor burden. This study aimed to assess the clinicopathological factors that predict non-SLN metastasis to define subgroups of SLN-positive patients in whom the axilla may be staged by SLN biopsy alone, while avoiding unnecessary overtreatment.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/18 - Chirurgia Generale
English
Breast neoplasms; nodal metastasis; sentinel lymph node; Adult; Aged; Aged, 80 and over; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Middle Aged; Prognosis; Receptor, ErbB-2; Retrospective Studies; Risk Factors; Sentinel Lymph Node; Sentinel Lymph Node Biopsy
Orsaria, P., Caredda, E., Genova, F., Materazzo, M., Capuano, I., Vanni, G., et al. (2018). Additional nodal disease prediction in breast cancer with sentinel lymph node metastasis based on clinicopathological features. ANTICANCER RESEARCH, 38(4), 2109-2117 [10.21873/anticanres.12451].
Orsaria, P; Caredda, E; Genova, F; Materazzo, M; Capuano, I; Vanni, G; Granai, Av; de Majo, A; Portarena, I; Sileri, P; Petrella, G; Palombi, L; Buonomo, Oc
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
1de31a59664108111620ea4b6a14f4cc.pdf

accesso solo dalla rete interna

Licenza: Copyright dell'editore
Dimensione 200.74 kB
Formato Adobe PDF
200.74 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/204077
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 19
social impact